Download the FREE app and view selected topics (Approximately 10%
of the content is viewable in the free app and tapping on the
locked topic will launch the in-app purchase screen).
AHFS Drug Information with extensive updated information on everything from treatment of hypertension to hepatitis C AHFS® Drug Information™ 2017 Edition is a necessary addition to your pharmacy’s resources.
With content supported by more than 86000 total references and reviewed by over 500 professionals AHFS DI® helps you protect your patients and your business. The only print compendium designated by the U.S. Congress AHFS DI® 2016 is also the only reference published by a professional and scientific society—ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 58 years.
AHFSI DI® contains the most trustworthy drug information available--all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
Updates for this edition include:
- Expanded and revised content throughout featuring critical new monograph updates every year
- Important updated monographs and references related to revised therapeutic guidelines
- Including revised recommendations for the treatment of HIV infections in adult and pediatric
patients
- Newly published information on breakthrough oncology drugs approved as part of the FDA’s
- Accelerated approval program
- Dedicated coverage to orphan products
- Interactions adverse reactions cautions and more
- Therapeutic recommendations supported by evidence from primary research
- Preparations chemistry and stability
- Pharmacology and pharmacokinetics
- Prescription OTC ophthalmic and dermatologic drugs
- Extensive off-label uses and dosing options
- Vaccines and other immunizing agents
SPECIAL FEATURES:
Locate a disease symptom or medication in the fastest possible manner:
- Navigate using multiple indices
- History to open frequently visited pages
- Bookmarks
NEVER FORGET ANYTHING:
- Add notes to topics
- Voice memos
AHFS Drug Information with extensive updated information on everything from treatment of hypertension to hepatitis C AHFS® Drug Information™ 2017 Edition is a necessary addition to your pharmacy’s resources.
With content supported by more than 86000 total references and reviewed by over 500 professionals AHFS DI® helps you protect your patients and your business. The only print compendium designated by the U.S. Congress AHFS DI® 2016 is also the only reference published by a professional and scientific society—ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 58 years.
AHFSI DI® contains the most trustworthy drug information available--all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.
Updates for this edition include:
- Expanded and revised content throughout featuring critical new monograph updates every year
- Important updated monographs and references related to revised therapeutic guidelines
- Including revised recommendations for the treatment of HIV infections in adult and pediatric
patients
- Newly published information on breakthrough oncology drugs approved as part of the FDA’s
- Accelerated approval program
- Dedicated coverage to orphan products
- Interactions adverse reactions cautions and more
- Therapeutic recommendations supported by evidence from primary research
- Preparations chemistry and stability
- Pharmacology and pharmacokinetics
- Prescription OTC ophthalmic and dermatologic drugs
- Extensive off-label uses and dosing options
- Vaccines and other immunizing agents
SPECIAL FEATURES:
Locate a disease symptom or medication in the fastest possible manner:
- Navigate using multiple indices
- History to open frequently visited pages
- Bookmarks
NEVER FORGET ANYTHING:
- Add notes to topics
- Voice memos
Show More >